Source: Virtual Congress 2020 – Reducing the burden of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Koppelman (Groningen, Netherlands). The genetics of asthma and the promise of genomics-guided drug discovery. Virtual Congress 2020 – Reducing the burden of asthma

Member's Comments

No comment yet.

Related content which might interest you: COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Human translational medicine in ILD: the promise of new drugs Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Comparative mycobacterial genomics as a tool for drug target and antigen discovery Source: Eur Respir J 2002; 20: 78S-86S Year: 2002 Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Source: Eur Respir J 2013; 42: 802-825 Year: 2013 The omics approach to defining endotypes and personalising treatment pathways in asthma Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016 NORDSTAR: paving the way for a new era in asthma research Source: Eur Respir J, 55 (4) 1902476; 10.1183/13993003.02476-2019 Year: 2020 New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 GWA to study the genetics of asthma and in other diseases - advances and challenges Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008 High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Source: Eur Respir J 2009; 33: 489-506 Year: 2009 The quest for the grail: multidimensional efforts for understanding and targeting severe asthma Source: Eur Respir J 2015; 46: 1227-1231 Year: 2015 Genetic studies as a tool for identifying novel potential targets for treatment of COPD Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017 Year: 2017 From genetical genomics to system genetics: application in asthma/COPD Source: ERS Research Seminar 2015 Year: 2015 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Current and emerging approaches to the genetic diagnosis of chILDs Source: International Congress 2014 – Interstitial lung disease (ILD) in children Year: 2014 Pharmacogenetics and asthma: false hope or new dawn? Source: Eur Respir J 2007; 29: 1239-1245 Year: 2007 Predictive and personalised medicine for asthma using genomics Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012